Concepedia

Vladimir Coric

VC

Statistics

Publications

61

Citations

5.2K

H-Index

34

Active since

1998

Affiliations

Biohaven Pharmaceuticals (United States)(Current)

Yale University

Albert Einstein College of Medicine

University of California, Los Angeles

Bristol-Myers Squibb (United States)

Vladimir Coric is an author at Biohaven Pharmaceuticals (United States) specializing in pharmacotherapy, pharmacology, and pharmacy.

Publications per year

1998–2024

61

Publications

61

Rimegepant, an Oral Calcitonin Gene–Related Peptide Receptor Antagonist, for Migraine

Richard B. Lipton, Robert Croop, Elyse Stock et al. · New England Journal of Medicine · 2019 · 396 citations · Full text

, , +14

Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial

Robert Croop, Peter J. Goadsby, David Stock et al. · The Lancet · 2019 · 392 citations

, , +12

Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease

Vladimir Coric, Christopher H. van Dyck, Stephen Salloway et al. · Archives of Neurology · 2012 · 369 citations

, , +17

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Robert Croop, Richard B. Lipton, David Kudrow et al. · The Lancet · 2020 · 351 citations

, , +12

Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture

Lea K. Davis, Dongmei Yu, Clare L. Keenan et al. · PLoS Genetics · 2013 · 344 citations · Full text

, , +17

1–5 of 61